blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1807698

EP1807698 - ASSAY FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY COMBINING FRET AND FLUORESCENCE POLARIZATION [Right-click to bookmark this link]
Former [2007/29]FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY
[2010/02]
StatusPatent revoked
Status updated on  15.04.2019
Database last updated on 06.07.2024
FormerThe patent has been granted
Status updated on  03.04.2017
Most recent event   Tooltip21.07.2017Revocation of patentpublished on 23.08.2017  [2017/34]
Applicant(s)For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
[N/P]
Former [2008/36]For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine CA 92612 / US
Former [2007/29]For all designated states
ALLERGAN, INC.
2525 Dupont Drive
Irvine, CA 92612 / US
Inventor(s)01 / WILLIAMS, Dudley, J.
11 Dunn Street
Laguna Niguel, CA 92677 / US
02 / GILMORE, Marcella, A.
13151 St. Thomas Drive
Santa Ana, CA 92705 / US
03 / STEWARD, Lance, E.
9 Woodfern
Irvine, CA 92614 / US
04 / VERHAGEN, Marc
14 Thunder Trail
Irvine, CA 92614 / US
05 / AOKI, Kei, Roger
2 Ginger Lily Court
Coto de Caza, CA 92679 / US
 [2007/29]
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[N/P]
Former [2007/29]HOFFMANN EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date05858107.509.09.2005
[2007/29]
WO2005US32328
Priority number, dateUS2004094809722.09.2004         Original published format: US 948097
[2007/29]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007001358
Date:04.01.2007
Language:EN
[2007/01]
Type: A2 Application without search report 
No.:EP1807698
Date:18.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
[2007/29]
Type: B1 Patent specification 
No.:EP1807698
Date:23.06.2010
Language:EN
[2010/25]
Search report(s)International search report - published on:EP28.06.2007
ClassificationIPC:C12N9/52, C12Q1/37, G01N33/542
[2012/50]
CPC:
G01N33/542 (EP,US); G01N33/52 (KR); C12N9/52 (EP,US);
C12Q1/00 (KR); C12Q1/37 (EP,US); G01N2333/33 (EP,US)
Former IPC [2007/29]G01N33/542, G01N33/536
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/29]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:Assay zur Bestimmung der Aktivität von Clostridien-Toxin mittels Kombination von FRET und Fluoreszenzpolarisation[2010/02]
English:ASSAY FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY COMBINING FRET AND FLUORESCENCE POLARIZATION[2010/02]
French:Méthode de détermination de l'activité d'une toxine clostridiale combinant FRET et polarisation de fluoresecnce[2010/02]
Former [2007/29]FLUORESZENZ-POLARISIERUNGS-ASSAYS ZUR BESTIMMUNG DER AKTIVITÄT VON CLOSTRIDIENTOXIN
Former [2007/29]FLUORESCENCE POLARIZATION ASSAYS FOR DETERMINING CLOSTRIDIAL TOXIN ACTIVITY
Former [2007/29]DOSAGES DE POLARISATION DE FLUORESCENCE DESTINÉS À DÉTERMINER L'ACTIVITÉ D'UNE TOXINE CLOSTRIDIALE
Entry into regional phase21.03.2007National basic fee paid 
21.03.2007Designation fee(s) paid 
21.03.2007Examination fee paid 
Examination procedure21.03.2007Examination requested  [2007/29]
17.08.2007Amendment by applicant (claims and/or description)
13.11.2007Despatch of a communication from the examining division (Time limit: M04)
25.01.2008Reply to a communication from the examining division
27.01.2009Despatch of a communication from the examining division (Time limit: M04)
21.04.2009Reply to a communication from the examining division
04.09.2009Despatch of a communication from the examining division (Time limit: M03)
12.10.2009Reply to a communication from the examining division
19.01.2010Communication of intention to grant the patent
29.04.2010Fee for grant paid
29.04.2010Fee for publishing/printing paid
Divisional application(s)EP09160607.9  / EP2107112
Opposition(s)Opponent(s)01  21.03.2011  21.04.2011  ADMISSIBLE
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt/Main / DE
Opponent's representative
Altmann Stößel Dick Patentanwälte PartG mbB
Isartorplatz 1
80331 München / DE
 [N/P]
Former [2015/25]
Opponent(s)01  21.03.2011  21.04.2011  ADMISSIBLE
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt/Main / DE
Opponent's representative
Herzog, Fiesser & Partner Patentanwälte PartG mbB
Isartorplatz 1
80331 München / DE
Former [2011/17]
Opponent(s)01  21.03.2011   
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt/Main / DE
Opponent's representative
Dick, Alexander
Herzog Fiesser & Partner Patentanwälte Bad Kreuznacher Strasse 27-29
68309 Mannheim / DE
03.05.2011Invitation to proprietor to file observations on the notice of opposition
06.10.2011Reply of patent proprietor to notice(s) of opposition
17.10.2012Date of oral proceedings
04.01.2013Despatch of interlocutory decision in opposition
04.01.2013Despatch of minutes of oral proceedings
14.01.2013Legal effect of interlocutory decision in opposition
28.07.2016Despatch of communication that the patent will be maintained as amended
04.04.2017Despatch of communication that the patent will be revoked
14.04.2017Legal effect of revocation of patent [2017/34]
Appeal following opposition12.03.2013Appeal received No.  T0660/13
14.05.2013Statement of grounds filed
07.07.2016Result of appeal procedure: other kind of disposal
12.03.2013Appeal received No.  T0660/13
12.04.2013Statement of grounds filed
04.03.2016Invitation to file observations in an appeal (Time limit: M02) [2016/10]
07.07.2016Result of appeal procedure: other kind of disposal
Fees paidRenewal fee
26.09.2007Renewal fee patent year 03
25.09.2008Renewal fee patent year 04
25.09.2009Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
GB09.09.2014
IE09.09.2014
IT09.09.2014
ES10.09.2014
SE10.09.2014
CH30.09.2014
DK30.09.2014
FR30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
[2016/10]
Former [2015/50]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
GB09.09.2014
IE09.09.2014
IT09.09.2014
SE10.09.2014
CH30.09.2014
DK30.09.2014
FR30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
Former [2015/38]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
GB09.09.2014
IE09.09.2014
IT09.09.2014
SE10.09.2014
CH30.09.2014
FR30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
Former [2015/37]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
GB09.09.2014
IE09.09.2014
IT09.09.2014
SE10.09.2014
CH30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
Former [2015/36]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
GB09.09.2014
SE10.09.2014
CH30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
Former [2015/35]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
SE10.09.2014
CH30.09.2014
LI30.09.2014
DE01.04.2015
NL01.04.2015
Former [2015/33]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
SE10.09.2014
CH30.09.2014
LI30.09.2014
NL01.04.2015
Former [2015/29]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
SE10.09.2014
NL01.04.2015
Former [2015/24]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
SE10.09.2014
Former [2013/42]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
TR23.06.2010
LU09.09.2010
BG23.09.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
HU24.12.2010
Former [2011/20]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
GR24.09.2010
MC30.09.2010
IS23.10.2010
PT25.10.2010
Former [2011/13]AT23.06.2010
BE23.06.2010
CY23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
GR24.09.2010
IS23.10.2010
PT25.10.2010
Former [2011/12]AT23.06.2010
CZ23.06.2010
EE23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
RO23.06.2010
SI23.06.2010
SK23.06.2010
GR24.09.2010
PT25.10.2010
Former [2011/04]AT23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
PL23.06.2010
SI23.06.2010
GR24.09.2010
Former [2011/02]AT23.06.2010
FI23.06.2010
LT23.06.2010
LV23.06.2010
SI23.06.2010
GR24.09.2010
Cited inInternational search[XY]WO2004031355  (UNIV MARYLAND [US]; OYLER GEORGE A [US]; TSAI YIEN CHE [US]; FISHMAN P) [X] 1,12,15-30,33,34 * --------- * * the whole document * * abstract * * page 6, paragraph 26 - paragraph 27 * * page 19, paragraph 65 * * claims 1,3,8-12,27 * [Y] 70;
 [A]US2001046668  (LEVINE LEANNA M [US], et al) [A] 1-77 * the whole document * * abstract * * page 1, paragraph 11; figure 2 * * page 2, paragraph 15 - paragraph 18 * * page 2, paragraph 21 - paragraph 22 * * page 2, paragraph 24 - paragraph 25 * * page 3, paragraph 41 * * page 4, paragraph 50 ** claims 1,3,4 *;
 [XY]WO0225284  (U S MEDICAL RES INST OF INFECT [US], et al) [X] 1-12,15-69,71-77 * --------- * * the whole document * * abstract * * page 6, line 33 - page 7, line 9 * * page 7, line 24 - line 27 * * page 9, line 29 - page 10, line 8 * * substrates (1)-(14);; page 9, line 29 - page 19, line 2 * * page 13, line 31 - page 14, line 2 * * page 14, line 17 - page 19, line 22 * * claims 1,8 * [Y] 70;
 [XY]WO03020948  (ALLERGAN INC [US]) [X] 1-12,15-32,35-69,71-77 * --------- * * the whole document * * abstract * * page 11, line 20 - page 14, line 11 * * page 14, line 12 - line 20 * * page 20, line 16 - line 25 * * page 86, line 3 - line 17 * * claims 18,20-24,35,38-44,48 * [Y] 70
ExaminationUS6337386
    - SCHMIDT J.J. ET AL, "High-throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D and F", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, NEW YORK, NY, US, 2001, (2001), vol. 296, pages 130 - 137, XP002975754

DOI:   http://dx.doi.org/10.1006/abio.2001.5236
    - EKONG T.A. ET AL, "Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.", MICROBIOLOGY (READING, ENGLAND) OCT 1997, (199710), vol. 143, pages 3337 - 3347, XP002424472
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.